In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF- in the lung
Open Access
- 1 October 2006
- Vol. 61 (10), 886-894
- https://doi.org/10.1136/thx.2005.056317
Abstract
Backgroud: Idiopathic pulmonary fibrosis is a devastating disorder for which there is no effective treatment. Transforming growth factor (TGF)-β plays a critical role in provoking fibrosis. Interleukin (IL)-10 is a potent immunosuppressive cytokine but its effect on the fibrosing process is unclear. A study was undertaken to examine whether IL-10 affects the production and activation of TGF-β and thus can attenuate the fibrosis. Methods: Mice were given an intratracheal injection of bleomycin. On day 1 or 14, IL-10 gene was delivered by rapid intravenous injection of Ringer’s solution containing plasmid. Two weeks after the plasmid injection the mice were examined for fibrosis. The effect of IL-10 on TGF-β production by alveolar macrophages was assessed. Results: Even when delivered during the fibrosing phase, IL-10 gene significantly suppressed the pathological findings, hydroxyproline content, and production of both active and total forms of TGF-β1 in the lung. Immunohistochemical analyses showed that alveolar macrophages were one of the major sources of TGF-β1 and IL-10 diminished the intensity of the staining. IL-10 also suppressed the expression of αVβ6 integrin, a molecule that plays an important role in TGF-β activation, on lung epithelial cells. Alveolar macrophages from bleomycin injected mice produced TGF-β1 spontaneously ex vivo, which was significantly suppressed by treatment of the mice in vivo or by treatment of the explanted macrophages ex vivo with IL-10. Conclusion: IL-10 suppresses the production and activation of TGF-β in the lung and thus attenuates pulmonary fibrosis, even when delivered in the chronic phase.Keywords
This publication has 39 references indexed in Scilit:
- Mechanisms of Pulmonary FibrosisAnnual Review of Medicine, 2004
- Idiopathic Pulmonary FibrosisDrugs, 2004
- Transforming Growth Factor (TGF)-β1–producing Regulatory T Cells Induce Smad-mediated Interleukin 10 Secretion That Facilitates Coordinated Immunoregulatory Activity and Amelioration of TGF-β1–mediated FibrosisThe Journal of Experimental Medicine, 2003
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamstersThorax, 1999
- Thrombospondin-1 Is a Major Activator of TGF-β1 In VivoCell, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.JCI Insight, 1998
- Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.JCI Insight, 1997
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991